NGL Fine Chem Ltd

NGL Fine Chem Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

NGL Fine Chem Ltd

₹ 1,251 2.96%
16 May - close price
nglfinechem.com BSE: 524774 NSE: NGLFINE
About

Established in 1981, NGL Fine-Chem Limited manufactures human and veterinary bulk drugs, intermediates, and formulations. It primarily deals in animal healthcare products such as antiprotozoal, anthelmintics, and growth promoters [1]

Key Points

Product Portfolio FY24
Presently, Veterinary APIs are the main product of the company which account for 89% of its revenues, followed by Veterinary Formulations (5%), Human APIs (3%), and Intermediates (3%).[1] The company has 26 APIs (24 Veterinary APIs, 2 Human APIs), 4 Intermediates and 10 finished dosage forms.[2]

Website BSE NSE - BE
  • Market Cap ₹ 773 Cr.
  • Current Price ₹ 1,251
  • High / Low ₹ 2,778 / 957
  • Stock P/E 23.7
  • Book Value ₹ 454
  • Dividend Yield 0.14 %
  • ROCE 20.4 %
  • ROE 17.0 %
  • Face Value ₹ 5.00
Edit ratios

Pros

Cons

  • Earnings include an other income of Rs.14.6 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Part of BSE Allcap BSE SmallCap BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
81.14 84.06 65.25 67.72 71.93 75.13 71.04 80.18 87.95 99.76 90.75 93.48 89.10
68.64 73.50 63.10 58.57 62.12 60.93 61.18 66.21 74.08 83.94 81.40 81.92 84.01
Operating Profit 12.50 10.56 2.15 9.15 9.81 14.20 9.86 13.97 13.87 15.82 9.35 11.56 5.09
OPM % 15.41% 12.56% 3.30% 13.51% 13.64% 18.90% 13.88% 17.42% 15.77% 15.86% 10.30% 12.37% 5.71%
3.84 2.98 2.50 0.47 0.69 0.87 3.32 3.22 3.68 3.68 5.88 5.12 -0.13
Interest 0.42 1.54 0.50 0.12 0.26 0.34 0.24 0.36 0.28 0.49 0.44 0.32 0.60
Depreciation 2.42 3.48 3.60 3.25 1.23 2.68 2.86 2.89 2.94 2.92 3.00 3.03 3.10
Profit before tax 13.50 8.52 0.55 6.25 9.01 12.05 10.08 13.94 14.33 16.09 11.79 13.33 1.26
Tax % 26.30% 19.60% 5.45% 25.44% 28.08% 22.66% 15.58% 24.82% 30.01% 23.43% 21.80% 26.41% -0.79%
9.95 6.87 0.52 4.67 6.49 9.32 8.51 10.48 10.03 12.32 9.22 9.81 1.28
EPS in Rs 16.11 11.12 0.84 7.56 10.51 15.09 13.77 16.96 16.24 19.94 14.92 15.88 2.07
Raw PDF
Upcoming result date: 22 May 2025

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
153 152 258 318 278 339 373
121 130 178 249 243 285 331
Operating Profit 32 22 80 68 35 54 42
OPM % 21% 14% 31% 21% 13% 16% 11%
4 1 8 11 6 14 15
Interest 3 3 2 2 2 2 2
Depreciation 6 8 8 10 11 12 12
Profit before tax 28 12 78 67 27 54 42
Tax % 27% 31% 27% 25% 25% 24%
20 8 57 50 20 41 33
EPS in Rs 32.58 13.50 91.81 80.77 33.18 66.88 52.81
Dividend Payout % 5% 13% 2% 2% 5% 3%
Compounded Sales Growth
10 Years: %
5 Years: 17%
3 Years: 10%
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: 15%
3 Years: -10%
TTM: -15%
Stock Price CAGR
10 Years: 27%
5 Years: 31%
3 Years: -14%
1 Year: -47%
Return on Equity
10 Years: %
5 Years: 21%
3 Years: 18%
Last Year: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 3 3 3 3 3 3 3
Reserves 89 96 151 200 219 260 277
27 28 16 30 32 34 49
23 26 36 44 32 59 66
Total Liabilities 142 154 207 277 287 356 396
61 68 64 89 88 86 89
CWIP 0 0 12 6 26 46 61
Investments 9 11 29 29 39 54 79
73 75 102 153 133 171 167
Total Assets 142 154 207 277 287 356 396

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
9 20 27 14 35 20
-10 -20 -25 -14 -27 -27
0 -1 -1 -1 -1 -1
Net Cash Flow -1 -0 2 -1 7 -7

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 79 63 53 74 86 97
Inventory Days 106 155 132 137 69 98
Days Payable 92 116 103 91 63 112
Cash Conversion Cycle 93 102 82 120 93 83
Working Capital Days 107 93 76 117 105 110
ROCE % 14% 54% 34% 12% 20%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
73.81% 73.81% 73.81% 73.53% 73.53% 73.06% 73.06% 72.74% 72.74% 72.74% 72.74% 72.74%
0.05% 0.05% 0.00% 0.00% 0.00% 0.02% 0.04% 0.10% 0.03% 0.02% 0.05% 0.00%
0.00% 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
26.14% 26.13% 26.19% 26.47% 26.46% 26.93% 26.91% 27.16% 27.24% 27.25% 27.23% 27.26%
No. of Shareholders 18,04218,50418,44018,28717,06617,62316,41015,04114,60814,57514,11014,386

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls